A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ≤30% blasts

G. Garcia-Manero, M. A. Sekeres, M. Egyed, M. Breccia, C. Graux, J. D. Cavenagh, H. Salman, A. Illes, P. Fenaux, D. J. Deangelo, R. Stauder, K. Yee, N. Zhu, J. H. Lee, D. Valcarcel, A. Macwhannell, Z. Borbenyi, L. Gazi, S. Acharyya, S. IdeM. Marker, O. G. Ottmann

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Fingerprint

Dive into the research topics of 'A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ≤30% blasts'. Together they form a unique fingerprint.

Medicine & Life Sciences